-
Something wrong with this record ?
Risk of visual axis opacification in infants with and without primary IOL implantation after congenital cataract surgery performed during the first 4 months of age
M. Hložánek, L. Cilečková, JL. Alió, R. Autrata, N. Zelenayová, M. Komínek, J. Cendelín, G. Mahelková
Language English Country Germany
Document type Journal Article
Grant support
00064203
Ministerstvo Zdravotnictví Ceské Republiky
NLK
ProQuest Central
from 1997-10-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2009-07-01 to 1 year ago
Health & Medicine (ProQuest)
from 1997-10-01 to 1 year ago
- MeSH
- Aphakia * complications MeSH
- Child MeSH
- Cataract Extraction * adverse effects MeSH
- Lens Implantation, Intraocular adverse effects MeSH
- Cataract * congenital MeSH
- Infant MeSH
- Humans MeSH
- Follow-Up Studies MeSH
- Lenses, Intraocular * adverse effects MeSH
- Postoperative Complications epidemiology MeSH
- Retrospective Studies MeSH
- Visual Acuity MeSH
- Check Tag
- Child MeSH
- Infant MeSH
- Humans MeSH
- Publication type
- Journal Article MeSH
PURPOSE: The study evaluates the rate of postoperative formation of a pupillary membrane (PM) and posterior visual axis opacification (PVAO) in infants with and without primary IOL implantation during the first 4 months of infancy. METHODS: Medical records for 144 eyes (101 infants) operated between 2005 and 2014 were evaluated. A posterior capsulectomy and anterior vitrectomy were performed. Primary IOL implantation was performed in 68 eyes, while 76 eyes were left aphakic. There were 16 bilateral cases in the pseudophakic group and 27 in the aphakic group. The follow-up period was 54.3 ± 21.05 months and 49.1 ± 18.60 months, respectively. Fisher's exact test was used for statistical analysis. The two-sample t-test with equal variance was used to compare surgery age, follow-up period and time intervals of complications. RESULTS: The mean age of surgery was 2.1 ± 0.85 months in the pseudophakic and 2.2 ± 1.01 months in the aphakic group. PM was diagnosed in 40% pseudophakic and 7% aphakic eyes. A second surgery for PVAO was performed in 72% pseudophakic and 16% aphakic eyes. Both were significantly higher in the pseudophakic group. In the pseudophakic group, the number of PVAO was significantly higher in infants operated before 8 weeks of age compared to surgery age 9-16 weeks. The frequency of PM was not age-dependent. CONCLUSION: Although it remains feasible to implant an IOL during the primary surgery, even in very young infants, there should always be solid arguments for this decision since it puts the child at higher risk of repeated surgeries under general anaesthesia.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24000548
- 003
- CZ-PrNML
- 005
- 20240213093241.0
- 007
- ta
- 008
- 240109s2023 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00417-023-06143-9 $2 doi
- 035 __
- $a (PubMed)37329362
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Hložánek, Martin $u Department of Ophthalmology for Children and Adults, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, 15006, Prague 5, Czech Republic. martin.hlozanek@fnmotol.cz $1 https://orcid.org/0000000279627783 $7 mzk2006356166
- 245 10
- $a Risk of visual axis opacification in infants with and without primary IOL implantation after congenital cataract surgery performed during the first 4 months of age / $c M. Hložánek, L. Cilečková, JL. Alió, R. Autrata, N. Zelenayová, M. Komínek, J. Cendelín, G. Mahelková
- 520 9_
- $a PURPOSE: The study evaluates the rate of postoperative formation of a pupillary membrane (PM) and posterior visual axis opacification (PVAO) in infants with and without primary IOL implantation during the first 4 months of infancy. METHODS: Medical records for 144 eyes (101 infants) operated between 2005 and 2014 were evaluated. A posterior capsulectomy and anterior vitrectomy were performed. Primary IOL implantation was performed in 68 eyes, while 76 eyes were left aphakic. There were 16 bilateral cases in the pseudophakic group and 27 in the aphakic group. The follow-up period was 54.3 ± 21.05 months and 49.1 ± 18.60 months, respectively. Fisher's exact test was used for statistical analysis. The two-sample t-test with equal variance was used to compare surgery age, follow-up period and time intervals of complications. RESULTS: The mean age of surgery was 2.1 ± 0.85 months in the pseudophakic and 2.2 ± 1.01 months in the aphakic group. PM was diagnosed in 40% pseudophakic and 7% aphakic eyes. A second surgery for PVAO was performed in 72% pseudophakic and 16% aphakic eyes. Both were significantly higher in the pseudophakic group. In the pseudophakic group, the number of PVAO was significantly higher in infants operated before 8 weeks of age compared to surgery age 9-16 weeks. The frequency of PM was not age-dependent. CONCLUSION: Although it remains feasible to implant an IOL during the primary surgery, even in very young infants, there should always be solid arguments for this decision since it puts the child at higher risk of repeated surgeries under general anaesthesia.
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a kojenec $7 D007223
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a implantace nitrooční čočky $x škodlivé účinky $7 D019654
- 650 _2
- $a zraková ostrost $7 D014792
- 650 12
- $a extrakce katarakty $x škodlivé účinky $7 D002387
- 650 12
- $a katarakta $x vrozené $7 D002386
- 650 12
- $a afakie $x komplikace $7 D001035
- 650 _2
- $a pooperační komplikace $x epidemiologie $7 D011183
- 650 _2
- $a následné studie $7 D005500
- 650 12
- $a nitrooční čočky $x škodlivé účinky $7 D007910
- 650 _2
- $a retrospektivní studie $7 D012189
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Cilečková, Lenka $u Department of Ophthalmology for Children and Adults, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, 15006, Prague 5, Czech Republic $1 https://orcid.org/0000000171575547
- 700 1_
- $a Alió, Jorge L $u Department of Pathology and Surgery (Ophthalmology), Faculty of Medicine, University Miguel Hernandez, Avenida de la Universidad, s/n, 03202 Elche, Alicante, Spain $u Vissum Miranza Instituto Oftalmologico de Alicante, C/Cabañal, 1, 03016, Alicante, Spain $1 https://orcid.org/0000000280821751 $7 ntk20221164166
- 700 1_
- $a Autrata, Rudolf $u Department of Paediatric Ophthalmology, Faculty of Medicine, Masaryk University and University Hospital Brno, Černopolní 9, 62500, Brno, Czech Republic $1 https://orcid.org/000000022689882X
- 700 1_
- $a Zelenayová, Nina $u Department of Ophthalmology for Children and Adults, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, 15006, Prague 5, Czech Republic $1 https://orcid.org/0000000244456072
- 700 1_
- $a Komínek, Martin $u Department of Paediatric Ophthalmology, Faculty of Medicine, Masaryk University and University Hospital Brno, Černopolní 9, 62500, Brno, Czech Republic $1 https://orcid.org/0000000183225165
- 700 1_
- $a Cendelín, Jiří $u Department of Ophthalmology for Children and Adults, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, 15006, Prague 5, Czech Republic $1 https://orcid.org/0000000253936641
- 700 1_
- $a Mahelková, Gabriela $u Department of Ophthalmology for Children and Adults, Second Faculty of Medicine, Charles University and Motol University Hospital, V Úvalu 84, 15006, Prague 5, Czech Republic $1 https://orcid.org/0000000222443617
- 773 0_
- $w MED00001940 $t Graefe's archive for clinical and experimental ophthalmology $x 1435-702X $g Roč. 261, č. 12 (2023), s. 3643-3649
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37329362 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240109 $b ABA008
- 991 __
- $a 20240213093238 $b ABA008
- 999 __
- $a ok $b bmc $g 2049293 $s 1210242
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 261 $c 12 $d 3643-3649 $e 20230617 $i 1435-702X $m Graefe's archive for clinical and experimental ophthalmology $n Graefes Arch Clin Exp Ophthalmol $x MED00001940
- GRA __
- $a 00064203 $p Ministerstvo Zdravotnictví Ceské Republiky
- LZP __
- $a Pubmed-20240109